Targeting the Aryl Hydrocarbon Receptor: The Potential of Indole Compounds in the Treatment of Cystic Fibrosis
Sen Hou, Qingkun Yue, Xia Hou, Qingtian Wu
TL;DR
This paper explores how indole compounds, which activate the AHR pathway, could offer new treatment options for cystic fibrosis by targeting inflammation and immune regulation.
Contribution
The study introduces indole compounds as a novel therapeutic approach for cystic fibrosis, distinct from traditional CFTR modulators.
Findings
Indole compounds may regulate pulmonary infection and inflammation in cystic fibrosis patients.
Activation of the AHR pathway could help repair intestinal barrier function in CF.
The study highlights potential risks and challenges in developing indole-based therapies for CF.
Abstract
The aryl hydrocarbon receptor (AHR), a ligand-activated transcription factor, plays a crucial role in regulating immune homeostasis, inflammatory responses, and intestinal barrier function. Indole compounds and their derivatives are ligands of AHR, which can activate the AHR signal transduction pathway and show significant regulatory potential in various inflammatory and immune diseases. Cystic fibrosis (CF) is a life-threatening autosomal recessive genetic disorder. Cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction affects multiple systems throughout the body. The core of its pathological process is chronic infection, abnormal inflammation, and tissue damage caused by mucus accumulation. Exploring alternative or adjunctive therapeutic strategies targeting pathological pathways downstream of CFTR is of significant importance. The aim of the present study is to…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10
Figure 11Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCystic Fibrosis Research Advances · Inhalation and Respiratory Drug Delivery · Neonatal Respiratory Health Research